Mitazalimab Uses, Dosage, Side Effects and more
Mitazalimab is under investigation in clinical trial NCT02379741 (ADC-1013 First-in-Human Study).
| Trade Name | Mitazalimab |
| Generic | Mitazalimab |
| Mitazalimab Other Names | Mitazalimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
